KLAC
57
3
HUM
42
-6
PM
66
2
TROW
51
-3
MDLZ
85
2
HCP
62
8
HES
66
3
AN
52
-2
AAL
33
-3
GPC
61
-3
NAVI
33
-16
DOW
54
7
TRV
43
-2
FLS
53
-2
DO
54
-6
QCOM
71
3
MAR
60
3
WFC
58
-3
FSLR
58
-3
TSCO
48
2
KLAC
57
3
HUM
42
-6
PM
66
2
TROW
51
-3
MDLZ
85
2
HCP
62
8
HES
66
3
AN
52
-2
AAL
33
-3
GPC
61
-3
NAVI
33
-16
DOW
54
7
TRV
43
-2
FLS
53
-2
DO
54
-6
QCOM
71
3
MAR
60
3
WFC
58
-3
FSLR
58
-3
TSCO
48
2
Financhill
Back

ITeos Therapeutics 10K Form

Sell
27

ITOS
ITeos Therapeutics

Last Price:
10.59
Seasonality Move:
-5.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ITOS News And Ratings

See the #1 stock for the next 7 days that we like better than ITOS

ITOS Financial Statistics

Sales & Book Value

Annual Sales: $12.6M
Cash Flow: $-15.16M
Price / Cash Flow: 0
Annual Sales: $16.05
Price / Book: 0.66

Profitability

EPS (TTM): -3.15000
Net Income (TTM): $-112.64M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

ITeos Therapeutics Earnings Forecast

Key ITeos Therapeutics Financial Ratios

  • The Research & Development expenses have been 899.56% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

ITeos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ITOS
CUSIP: 46565G
Website: iteostherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ITOS Technical Analysis vs Fundamental Analysis

Sell
27
ITeos Therapeutics (ITOS) is a Sell

Is ITeos Therapeutics a Buy or a Sell?